642
Participants
Start Date
July 31, 2014
Primary Completion Date
July 31, 2016
Study Completion Date
August 31, 2016
Thalidomide
100 mg by mouth twice a day on days 1-5 after chemotherapy, cycle 1
Placebo for thalidomide
Placebo tablet manufactured to mimic Thalidomide 25 mg tablet 100 mg by mouth twice a day on days 1-5 after chemotherapy , cycle 1
Palonosetron and Dexamethasone
Palonosetron 0.25 mg intravenously on day 1; Dexamethasone 12 mg by mouth or intravenously before chemotherapy on day 1 and 8 mg on days 2-4; cycle 1.
The First Hospital of China Medical University, Shenyang
Shengjing Hospital of China Medical University, Shenyang
Anshan Tumor Hospital, Anshan
Second Affiliated Hospital of Dalian Medical University, Dalian
The First Affiliated Hospital of Dalian Medical University, Dalian
The First Hospital of Liaoning Medical University, Jinzhou
Liaoyang Central Hospital, Liaoyang
Petrochemical General Hospital of Liaoyang city, Liaoyang
Third People's hospital Liaoyang, Liaoyang
General Hospital of Shenyang Military Region, Shenyang
Liaoning Tumor Hospital & Institute, Shenyang
The First Hospital of Liaoning Medical University
UNKNOWN
The First Affiliated Hospital of Dalian Medical University
OTHER
The Second Affiliated Hospital of Dalian Medical University
OTHER
Liaoning Cancer Hospital & Institute
OTHER
Shengjing Hospital
OTHER
General Hospital of Shenyang Military Region
OTHER
Liaoyang Central Hospital
OTHER
Third People's hospital Liaoyang
OTHER
Petrochemical General Hospital of Liaoyang city
UNKNOWN
Anshan Tumor Hospital
OTHER
China Medical University, China
OTHER